criteria for semaglutide BMI & the Role of GLP-1 in Weight Loss A newly approved 7.2-mg dose

Medication adjustments should always be discussed with your prescribing clinician

Lindsay is an E-RYT 500 yoga instructor, certified Pilates teacher, Reiki master, and holds a Master of Science in holistic nutrition, bringing a practitioners perspective to every project, bridging physical training, metabolic health, and consciousness-based wellness to support clear, engaging, publication-ready content

gastrointestinal adverse events (nausea, diarrhea, vomiting) were common but generally mild to moderate

Neither tirzepatide nor semaglutide increased the risk for serious adverse events or severe hypoglycaemia

Pharmacologic Overview of GLP-1 Receptor Agonists Mechanism of Action Endogenous GLP-1 is an incretin hormone secreted by intestinal L-cells postprandially

Orforglipron: Phase 3 trial results are expected in 2025